![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SANOFI-AVENTIS LAUNCHES ADACEL VACCINE IN U.S.
SANOFI-AVENTIS LAUNCHES ADACEL VACCINE IN U.S.
Sanofi-Aventis has launched its whooping cough vaccine Adacel in the United States, the world's third largest drugmaker said on Monday. Adacel, which combines whooping cough vaccine with routine tetanus and diphtheria booster shots, was cleared last month for marketing by the U.S. Food and Drug Administration (FDA) for people aged 11 to 64 years.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct